Natalie serkova, Ph. D. Current Title



Download 376.88 Kb.
Page3/4
Date02.02.2017
Size376.88 Kb.
#14991
1   2   3   4

Serkova NJ, Standiford TJ, Stringer KA: The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Review. Am J Respir Crit Care Med 184: 647-655, 2011 [PMID 21680948].

  • Comments: Bos LD, Sterk PJ, Schulz MJ: Measuring metabolomics in acute lung injury: choosing the correct compartment? Am J Respir Crit Care Med 185: 789, 2012 [PMID 22467809].

  1. Sargsyan SA, Serkova NJ, Renner B, Hasebroock KM, Larsen B, Stoldt C, McFann K, Pickering MC, Thurman JM: Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis. Kidney Int 81: 152-159, 2012 [PMID 21956190].

  2. Morelli MP, Tentler JT, Kulikowski GN, Tan AC, Bradshaw-Pierce EL, Pitts TM, Brown AM, Nallapareddy S, Acaroli JJ, Serkova NJ, Hidalgo M, Ciardiello F, Eckhardt SG: Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS mutant colorectal cancer models. Clin Cancer Res 18: 1051-1062, 2012 [PMID 22173548].

  3. Serkova NJ, Brown MS: Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers. Bioanalysis 4: 321-341, 2012 [PMID 22303835].

  4. Beresford TP, Fay T, Serkova N, Wu PH: Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice. J Pharmacol Exp Ther 341: 611-616, 2012 [PMID 22375069].

  5. Larsen BA, Hurst KM, Ashurst WR, Serkova NJ, Stoldt CR: Mono and dialkoxysilane surface modification of superparamagnetic iron oxide nanoparticles for application as magnetic resonance imaging contrast agents. J Material Res 27: 1846-1852, 2012.

  6. Raina K, Rajamanickam S, Ravichandran K, Huber KM, Serkova NJ, Agarwal R: Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: A multiparametric magnetic resonance study. Cancer Res Prev 6: 40-50, 2013 [PMID 23213071]. - January 2013 Cancer Prev Res Journal Cover Page Coverage.

  7. Yap TA, Arkenau HT, Camidge DR, George S, Serkova NJ, Gwyther SJ, Spratlin JL, Lal R, Spicer J, Desouza N, Leach M, Chick J, Poondru S, Boinpally R, Gedrich R, Brock K, Stephens A, Eckhardt SG, Kaye S, Demetri G, Scurr M: First-in-human Phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies. Clin Cancer Res 19: 909-919, 2013 [PMID 23403628].

  8. Raina K, Agarwal C, Wadhwa R, Serkova NJ, Agarwal R: Energy deprivation by silibinin in colorectal-cancer cells: A double edged sword targeting both apoptotic and autophagic machinery. Autophagy 9: 697-713, 2013 [PMID 23445752].

  9. Bradshaw-Pierce EL, Pitts TM, Kulikowski G, Selby H, Merz AL, Gustafson DL, Serkova NJ, Eckhardt SG, Weekes CD: Utilization of quantitative pharmacology approach to assess the combination effects of everolimus and irinotecan in murine xenograft models of colorectal cancer. PLoS One 8(3): e58089, 2013 [PMID 23520486].

  10. Weitzel L, Ambardekar AV, Brieke A, Cleveland JC, Serkova NJ, Wischmeyer PE, Lowes BD: Left ventricular assist device effects on metabolic substrates in the failing heart. PLoS One 8(4): e60292, 2013 [PMID 23560088].

  11. Derry M, Raina K, Balaiya V, Jain AK, Shrotriya S, Huber KM, Serkova NJ, Agarwal R, Agarwal C: Grape seed extract efficacy against azoxymethane-induced colon tomorigenesis in A/J mice: Interlinking miRNA with cytokine signaling and inflammation. Cancer Res Prev 6(7): 625-633, 2013 [PMID 23639480].

  12. Wilson J, Higgins D, Hutting H, Serkova N, Baird C, Khailova L, Queensland K, Weitzel L, Tran ZV, Wischmeyer PE: Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. Crit Care 2013 Sep 10; 17(5): R195. [Epub ahead of print] [PMID 24020447].

  13. Epple LM, Dodd RD, Merz AL, Dechkovskaia AM, Herring M, Winston BA, Lencioni AM, Russell RL, Madsen H, Nega M, Dusto NL, White J, Bigner DD, Nicchitta CV, Serkova NJ, Graner MW: Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells. PLoS One 8(8): e73267, 2013 [PMID 24039668].

  14. Yang X, La Rosa FG, Genova EE, Huber K, Schaack J, Degregori J, Serkova NJ, Li Y, Su LJ, Kessler E, Flaig TW: Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia. PLoS One 8(9): e74809, 2013 [PMID 24058630].

  15. Serkova NJ: New advances and state-of-the-art MR spectroscopy in oncology. Current Molecular Imaging [in press].

  16. Thurman JM, Serkova NJ: Nano-sized contrast agents to non-invasively detect renal inflammation. Journal of Renal Disease [in press].



Submitted Manuscripts:

  1. Epple LM, Dodd RD, Merz AL, Dechkovskaia AM, Herring M, Winston BA, Nega M, Dusto NL, White J, Bigner DD, Serkova NJ, Graner MW: The unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells. PLoS ONE.

  2. Alvarez-Calderon F, Gregory MA, Zaberezhnyy V, Gemta L, Serkova N, DeGregori: “BCR-ABL inhibition results in mitochondrial metabolic addictions in leukemia” to Blood.

  3. Serkova NJ, Boyes SG: Development of targeted nanoparticles for molecular imaging. Expert Opinion on Drug Metabolism and Toxicology [in press].


Manuscripts In Preparation:

  1. Serkova NJ, Bradshaw-Pierce EL, Huber KM, Merz AL, Pitts TM, Eckhardt SG: “Multiparametric imaging response to IGF1R inhibition in mouse colorectal cancer models” to Clinical Cancer Research.

  2. Bluth JS, Loram LC, Brown MS, Huber KM, Miller DE, Watkins LR, Serkova NJ: ”Magnetic resonance imaging (MRI) detection of spinal lesions ina rat MS model” to Magnetic Resonance in Medicine.

  3. Kominsky DJ, Brown JL, Bradshaw-Pierce EL, Frederick B, Raben D, Gustafson DL, Serkova NJ: “EGFR- and VEGFR-mediated metabolic response in human head and neck carcinoma models” to Cancer Research.

  4. Bradshaw-Pierce EL, Rowe M, Huber KM, Merz AL, Boyes S, Serkova NJ: “Molecular magnetic resonance imaging (MRI) of EGFR using targeted gadolinium nanoparticles” to Clinical Cancer Research.

  5. Klawitter J, Trump S, Morrow M, Brown JL, Eckhardt SG, Serkova NJ: “Metabolic signature of the EGFR inhibitor gefitinib in combination with 5-FU in human colorectal cancel cell lines” to Clinical Cancer Research.

  6. Coatney JL, Bradshaw-Pierce EL, Hasebroock KM, Levi M and Serkova NJ: “Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to assess renal functions in 5/6 mouse nephrectomy model” to Magnetic Resonance in Medicine.

  7. Bradshaw-Pierce EL, Huber KM, Merz AL, Serkova NJ: “Multiparametric imaging and NMR metabolomics to assess effects of enzastaurine in mouse colorectal xenografts” to Clinical Cancer Research.

  8. Wise-Faberowski L, Kominsky DJ, Peluso B, Beckey VE, Serkova NJ: “The age-dependent response to hypoxia in the rat: 1H- and 31P-NMR metabolomics study” to Brain Research.

  9. Niemann CU, Karnovsky A, Dang K, Merz AL, Serkova NJ: “Metabolic profiles of renal ischemia-reperfusion injury in acute and prolonged hyperglycemic rats” to Journal of Proteome Research.

  10. Serkova NJ, Robinson D, Merz AL, Huber KM, Bradshaw-Pierce EL: “TWEAK inhibition results in decreased glucose uptake by FDG-PET and lipid accumulation by NMR-metabolomics in mouse lung xenografts” to Clinical Cancer Research.

  11. Serkova NJ, Smith-Jones P, Aboagye E: “Animal Multimodality Imaging” to Radiology.

  12. Serkova NJ, McClure WC, Huber KM, Tseng BS: “Gadolinium-enhanced T1-MRI pinpoints skeletal muscle pathologyand metabolic dysfunctions in dystrophin deficient mice” to Magnetic Resonance in Medicine.

  13. Habekorn C, Garcia L, Merz AL, Pitts T, Eckhardt SG, Serkova NJ: “Metabolic signature of IGF1R-pathway inhibition in colorectal cancer cells” to Clinical Cancer Research.

  14. Anderson N, Klawitter J, Merz AL, Druker B, Eckhardt SG, Serkova NJ: “Role of BCR-ABL in metabolic re-programing” to Clinical Cancer Research.

  15. Serkova NJ, Eckhardt SG: “Metabolic signature of signal transduction inhibition” to Clinical Cancer Research.

  16. Reisdorph N, Prenni J, Kechris K, Serkova NJ: “Multi-platform metabolomics: From the collection to the analysis” to Analytical Biochemistry.

  17. Serkova NJ, Coatney JL, Karnovsky A, Geselkovich M, Lapin W, Cromer D, Mandell MS, Niemann CU: “Blood metabolomics in renal transplant patients” to Journal of Clinical Investigations.

  18. DeRyckere D, Macy ME, Huber KM, Gardner LA, Jedlika P, Merz AL, Gore L, Serkova NJ: “Lipogenesis and metabolic re-programing correlates with decreased T1-relaxation time and leukogenesis in MLL-AF9 transgenic mice” to Magnetic Resonance in Medicine.

  19. Frey L, Lepkin A, Schickedanz A, Hasebroock KM, Brown MS, Serkova NJ: “ADC mapping and T1-weighted signal changes on post-injury MRI predict seizure susceptibility and gross vestibulomotor outcome after experimental brain injury” to Journal of Cerebral Blood Flow and Metabolism.

  20. Serkova NJ, Merz AL, Wilson L, Weekes CD: “Metabolic response to mTOR inhibition in pancreatic cancer cell lines” to Clinical Cancer Research.

  21. Serkova NJ: “Tissue metabolome: Effects of various extractions on quantitative NMR-metabolomics” to Bioanalysis.




  1. Peer-Reviewed Conference Abstracts

  1. Brand, A., Flögel, U., Richter-Landsberg, C., Serkowa, N., Leibfritz, D.: Mechanism of osmoregulation in neuronal and glial cells in culture: A multinuclear magnetic resonance study. International Society of Development in Neuroscience, San Diego, CA, August 1.-5., 1994.

  2. Flögel, U., Niendorf, T., Serkowa, N., Brand, A., Henke, J., Leibfritz, D.: The role of organic solutes in volume-/osmoregulation of glial cells. 2nd Meeting of the Society of Magnetic Resonance, San Francisco, CA, August 6.-12., 1994

  3. Leibfritz, D., Flögel, U., Niendorf, T., Serkowa, N., Brand, A.: On line monitoring of cell volume and osmolyte concentrations in glial and neuronal cells after osmotic stress by multinuclear magnetic resonance spectroscopy, EUSEB Meeting: Basic and Clinical Neuroscience 93, Prague, Czech, September 12.-17., 1994.

  4. Serkowa, N., Leibfritz, D.: Einfluß von Immunsuppressiva auf neuronale und gliale Zellinien nachgewiesen mit NMR. 16th Symposium of the GDCh-Schwerpunkt: Magnetische Resonanz an biologischen Systemen, Witzenhausen, Germany, September 28.-October 1., 1994.

  5. Flögel, U., Brand, A., Serkowa, N., Niendorf, T., Leibfritz, D.: Untersuchungen zur Osmo- und Volumenregulation von Zellen mittels NMR-Spektroskopie. 16th Symposium of the GDCh-Schwerpunkt: Magnetische Resonanz an biologischen Systemen, Witzenhausen, Germany, September 28.-October 1., 1994.

  6. Brand, A., Serkowa, N., Flögel, U., Leibfritz, D.: Volume-/osmoregulation in primary neurons and astrocytes in culture. 3rd Scientific Meeting of the Society of Magnetic Resonance, Nice, France, August 19.-25., 1995.

  7. Serkowa, N., Brand, A., Leibfritz, D.: Metabolic response of primary astrocytes on immunosuppressive stress. 3rd Scientific Meeting of the Society of Magnetic Resonance, Nice, France, August 19.-25., 1995.

  8. Serkova, N., Pfeuffer, J., Flögel, U., Leibfritz, D.: Astrocyte swelling and changes in metabolite concentrations during immunosuppressive stress. 4th Scientific Meeting of the Society of Magnetic Resonance, New York, NY, April 27.-May 3., 1996.

  9. Serkova, N., Flögel, U., Pfeuffer, J., Leibfritz, D.: Volume regulation and metabolic alterations in primary astrocytes upon osmotic stress. 4th Scientific Meeting of the Society of Magnetic Resonance, New York, NY, April 27.-May 3., 1996.

  10. Pfeuffer, J., Flögel, U., Serkova, N., Dreher, W., Leibfritz, D.: Restricted diffusion and exchange of water in perfused cell cultures studied by two-dimensional MR measurements. 4th Scientific Meeting of the Society of Magnetic Resonance, New York, NY, April 27.-May 3., 1996.

  11. Serkova, N., Flögel, U., Pfeuffer, J., Leibfritz, D.: NMR application to the evaluation of volume regulation in primary astrocytes under pathological conditions, 13th European Experimental N.M.R. Conference, Paris, France, May 19.-24., 1996.

  12. Serkova, N., Flögel, U., Pfeuffer, J., Brand, A., Leibfritz, D.: Astrocyte swelling and metabolic alterations upon osmotic stress by multinuclear MRS. 11th European Society for Neurochemistry Meeting, Groningen, Netherlands, June 15.-20., 1996.

  13. Pfeuffer, J., Flögel, U., Serkova, N., Dreher, W., Leibfritz, D.: Water diffusion measurements in perfused cell cultures: Can mercurials induce permeability changes in glial cells? 13th Annual Meeting European Society for Magnetic Resonance in Medicine and Biology, Prague, Czech, September 12.-15., 1996.

  14. Serkova, N., Pfeuffer, J., Flögel, U., Christians, U., Leibfritz, D.: The mechanisms of astrocyte swelling induced by the immunosuppressant cyclosporine: A multinuclear NMR study. 16th International Society of Neurochemistry Meeting, Boston, MA, July 20.-26., 1997.

  15. Serkova, N., Pfeuffer, J., Flögel, U., James, T., Leibfritz, D., Christians, U.: Neurotoxic effects of immunosuppressants investigated by multinuclear NMR spectroscopy in vitro. 5th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Vancouver, Canada, November 10.-14., 1997.

  16. Serkova, N., Litt, L., Leibfritz, D., Morris, R.E., Benet, L.Z., Christians, U., James, T.L.: Using 31P-NMR spectroscopy of brain slices to determine neurotoxicity of novel immunosuppressants. 8th International Conference on Magnetic Resonance in Biological Systems, Tokyo, Japan, August 23.-28., 1998.

  17. Serkova, N., James, T.L., Benet, L.Z., Christians, U.: Neurotoxicity of novel macrolide immunosuppressants in rat brain slices: combination with cyclosporine. 1998 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, San Francisco, CA, November 15.-19., 1998.

  18. Christians, U., Serkova N.: Erwünschte und unerwünschte Wirkungen von Immunsuppressiva – Basieren Immunsuppression und Toxizität auf demselben molekularen Mechanismus? Früjahrstatung der Deutschen Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie, Mainz, Germany, March 9.-12., 1999.

  19. Serkova, N., Litt, L., James, T.L., Morris, R.E., Benet, L.Z., Christians, U.: Role of calcineurin and immunophilins in the decrease of brain energy metabolism caused by immunosuppressants. 38th Annual Meeting of the Society of Toxicology (SOT), New Orleans, LO, March 14.-18., 1999.

  20. Ikonen, T.S., Gummert, J.F., Honda, Y., Hayase, M., Kobayashi, Y., Hausen, B.A., Barlowm C.W., Pelroth, J.D., Serkova, N., Christians, U., Fitzgerald, P., Berry, G.J., Yock, P.G., Morris, RE.: Sirolimus (rapamycin) reverses the of graft vascular disease in non-human primate recipients of aortic allografts. 19th Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT), San Francisco, CA, April 21.-24., 1999.

  21. Serkova, N., Litt, L., Leibfritz, D., James, T.L., Benet, L.Z., Christians, U.: Preclinical 31P-MRS assessment of the neurotoxic potential and drug interaction of immunosuppressants used in organ transplantation. 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Philadelphia, MD, May 22.-28., 1999.

  22. Serkova, N., Litt, L., Leibfritz, D., James, T.L., Benet, L.Z., Christians, U.: The novel immunosuppressant SDZ-RAD antagonizes cyclosporine-induced reduction of brain energy. 6th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Cairns, Australia, September 13.-17., 1999.

  23. Serkova, N., Hausen, B., Morris, R.E., Benet, L.Z., Christians, U.: Tissue distribution of the novel macrolide immunosuppressant SDZ-RAD: Interaction with cyclosporine. 6th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Cairns, Australia, September 13.-17., 1999.

  24. Christians, U., Jacobsen, W., Serkova, N., Baner, K., Benet, L.Z.: An automated, specific assay to quantify cyclosporine and macrolide immunosuppressants in blood using LC/LC-MSD. 6th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Cairns, Australia, September 13.-17., 1999.

  25. Serkova, N., Donohoe, P., Leibfritz, D., Benet, L.Z., Litt, L., Christians, U.: Metabolic neurotoxicity and hypoxic neuroprotection of cyclosporine in brain slices: evidence that both occur from mitochondrial interactions. 29th Annual Meeting of the Society for Neuroscience, Miami Beach, FL, October 23.-28., 1999.

  26. Jacobsen, W., Serkova, N., Hallensleben, K., Sewing, K., Benet, L.Z., Christians, U.: In vitro metabolism of the novel immunosuppressant SDZ-RAD and comparison with rapamycin. 9th North American Meeting of International Society of Study Xenobiotics (ISSX), Nashville, TN, October 24.-28., 1999.

  27. Serkova, N., Jacobsen, W., Litt, L., Benet, L.Z., Leibfritz, D., Christians, U.: SDZ-RAD prevents inhibition of brain energy metabolism: comparison with rapamycin. Transplant2000, 1st Joint Transplant Meeting of the American Society of Transplantation (AST), Chicago, IL, May 13.-17., 2000.

  28. Serkova, N., Basus, V., James, T.L., Litt, L.: [1-13C]Fructose-1,6-biphosphate protection of glucose metabolism during hypoxia: 13C/1H-MRS on perfused rat brain slices. 19th International Conference on Magnetic Resonance in Biological Systems, Florence, Italy, August 20.-25., 2000.

  29. Serkova, N., Litt, L., Benet, L.Z., James, T.L., Leibfritz, D., Christians, U.: MRS evaluation of metabolic neurotoxicity in the rat as a preclinical test for novel immunosuppressive drugs. 19th International Conference on Magnetic Resonance in Biological Systems, Florence, Italy, August 20.-25., 2000.

  30. Serkova, N., Jacobsen, W., Hausen, B., Morris, R.E., Benet, L.Z., Leibfritz, D., Christians, U.: RAD, but not sirolimus, reverses the inhibition of brain metabolism by cyclosporine in the rat. 18th International Congress of the Transplantation Society, Rome, Italy, August 27.-September 1., 2000.

  31. Jacobsen, W., Serkova, N., Hausen, B., Morris, R., Benet, L., Christians, U.: Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. 18th International Congress of the Transplantation Society, Rome, Italy, August 27.-September 1., 2000.

  32. Christians, U., Serkova, N., Leibfritz, D., Benet L.Z.: Novel immunosuppressive strategies in transplantation medicine. 18th International Congress of the Transplantation Society, Rome, Italy, August 27.-September 1., 2000.

  33. Serkova, N., Donohoe, P., Niemann, C.U., Litt, L., Benet, L.Z., Leibfritz, D., Christians, U.: Cyclosporine-related mitochondrial effects in normoxia vs. hypoxia: 31P-MRS of perfused rat brain slices. 17th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Paris, France, September 14.-17., 2000.

  34. Litt, L., Hirai, K., Basus, V., Serkova, N., Develey, B., James, T.L.: Fructose-1,6-biphosphate protection of glucose metabolism during hypoxia: 13C/ 1H/ 31P NMR studies of perfused rat brain slives at 14.1 Tesla. 30th Annual Meeting of the Society for Neuroscience, New Orleans, LO, November 4.-9., 2000.

  35. Gottschalk, S., Hainz, S., Benet, L.Z., Leibfritz, D., Christians, U., Serkova, N: Metabolic neurotoxicity of immunosuppressants in the rat: Correlation between MRS and biochemical findings. 40th Annual Meeting of the Society of Toxicology, San Francisco, CA, March 25.-29., 2001.

  36. Hainz, C., Gottschalk, S., Jacobsen, W., Benet, L.Z., Leibfritz, D., Christians, U., Serkova, N.: MRS evaluations of metabolic changes by cyclosporine in rat brain: Role of the blood-brain-barrier. 40th Annual Meeting of the Society of Toxicology, San Francisco, CA, March 25.-29., 2001.

  37. Serkova, N., Donohoe, P., Gottschalk, S., Hainz, C., Christians, U., Leibfritz, D.: From metabolic neurotoxicity to hypoxic neuroprotection: an MRS study of cyclosporine role in rat brain. 9th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Glasgow, Scotland, UK, April 21.-27., 2001.

  38. Serkova, N., Gottschalk, S., Hainz, C., Benet, L.Z., Leibfritz, D., Christians, U.: Metabolic nephrotoxicity by cyclosporine in combination with macrolides: Comparison of SDZ-RAD vs. sirolimus. Transplant2001, 2nd Joint Transplant Meeting of the American Society of Transplantation (AST), Chicago, IL, May 11.-16., 2001.

  39. Jacobsen, W., Niemann, C., Unger, M., Serkova, N., Hirai, S., Benet, L.Z., Christians, U.: Automated, fast and sensitive quantification of drugs in human plasma by LC/LC-MS: Protease inhibitors and non-nucleoside reverse transcriptase inhibitors. 2001 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Denver, CO, October 19.-26., 2001.

  40. Serkova, N., Jacobsen, W., Leibfritz, D., Christians, U., Niemann, C.U.: Organ-specific metabolic response to cyclosporine treatment in rat liver, kidney, and heart: is there an evidence of preconditioning? 2nd Winter Symposium of the American Society of Transplant Surgeon (ASTS), Miami Beach, FL, January 25.-27., 2002.

  41. Serkova, N., Niemann, C.U., Saeed, M., Gottschalk, S., Benet, L.Z., Leibfritz, D., Christians. U.: Cardiac energy depression by cyclosporine prior to occlusion protects rat heart during ischemic insult. 10th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Honolulu, Hawaii, May 18.-24., 2002.

  42. Gottschalk, S., Hainz, C., Leibfritz, D., Serkova, N.: MRS evaluations of the metabolic response of human leukemia cells to a new tyrosine kinase inhibitor gleevec. 10th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Honolulu, Hawaii, May 18.-24., 2002.

  43. Gottschalk, S., Hainz, C., Miljus, J., Benet, L.Z., Christians, U., Leibfritz, D., Serkova, N.: Metabolic response and free radical formation by cyclosporine and macrolide immunosuppressants in rat brain slices. 14th World Congress of Pharmacology, San Francisco, CA, July 7.-12., 2002.

  44. Wischmeyer, P.E., Singleton, K.D., Serkova, N.: Glutamine preserves ATP levels and decreases tissue lactate in the myocardium following sublethal endotoxin shock. 25th Annual Conference on Shock, Big Sky, MO, June 8.-11., 2002.

  45. Singleton, K.D., Serkova, N., Song, Y., Banerjee, A., Meng, X., Camboni-Robertson, F., Wischmeyer, P.E.: Glutamine enhances heat shock protein 72 expression and preserves high energy phosphate levels in lung tissue following sublethal endotoxin shock. 25th Annual Conference on Shock, Big Sky, MO, June 8.-11., 2002.

  46. Christians, U., Serkova, N.: Interaction and toxicity of calcineurin and TOR inhibitors. 19th International Congress of Transplantation Society, Miami, FL, August 25.-30., 2002.

  47. Serkova, N., Frisch, L.: MRS assessment on metabolic response to imatinib in human chronic myelogenious leukemia cells. ISMRM Workshop on In Vivo Functional and Molecular Assessment of Cancer, Santa Cruz, CA, October 18.-21., 2002.

  48. Serkova, N., Christians, U., Henthorn, T.K.: Magnetic resonance (MRI/MRS) in biomedical research: Metabonomics for drug efficacy and toxicity. BioExpo, Denver, CO, December 4., 2002

  49. Wiscmeyer, P.E., Jayakar, D., Williams, U., Singleton, K.D., Serkova, N.: Sigle dose of glutamine preserves myocardial tissue metabolism, glutathione content, and enhances myocardial function following ischemia-reperfusion injury. Nutrition Week, San Antonio, TX, January 18.-22., 2003.

  50. Singleton KD, Serkova N, Wischmeyer PE: Glutamine attenuates the metabolic dysfunction of sublethal endotoxin shock via manipulation of the heat stress protein pathway. Shock Society Meeting, Phoenix, AR, 2003.

  51. Wischmeyer PE, Singleton KD, Serkova N: Glutamine attenuates sepsis-induced metabolic dysfunction following cecal ligation and puncture. Shock Society Meeting, Phoenix, AR, 2003.

  52. Tissot van Patot, M., Langston, M., Wickham, B., Bendrick-Peart, J., Serkova, N.: Increased hypoxia-inducible transcription factor activity correlates with increased anaerobic metabolism in placentas. 13th International Hypoxia Symposium, Banff, Alberta, Canada, February 19.-22., 2003.

  53. Christians. U., Serkova, N.J.: Magnetic resonance spectroscopy as a tool to identify mechanisms of immunosuppressant toxicity. 42nd Annual Meeting of the Society of Toxicology (SOT), Salt Lake City, UT, March 9.-13., 2003 (invited).

  54. Fuller, F., Serkova, N., Niemann, C.U., Freise, C.: Influence of donor pretreatment with N-acetylcysteine on rat kidney graft viability. 81st Annual Meeting of the American Urological Association (AUA), Chicago, IL, April 26.-May 1., 2003.

  55. Serkova, N.J., Fuller, F., Freise, C., Niemann, C.U.: Cellular oxidative injury in transplanted rat kidneys as determined by high-resolution 1H-MRS. 11th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM),Toronto, ON, May 9.-11., 2003.

  56. Mandell, M., Biancofiore, G., Kindscher, J., Stapefeldt, W., Serkova, N., Plevak, D., Niemann, C.: The safety of early extubation in liver transplant recipients. 9th Congress of the International Liver Transplantation Society (ILTS), Barcelona, Spain, June 18.-21., 2003.

  57. Anderson N and Serkova N: Metabolic and molecular response to imatinib treatment in human leukemia cells. 26th German Cancer Congress, Berlin, Germany, March 1.-3., 2004.

  58. Anderson N, Miljus J, Serkova N: Time dependent metabolic effects of imatinib on human leukemia cells. 95th Annual Meeting of American Association for Cancer Research (AACR), Orlando, FL, March 27.-31., 2004.

  59. Serkova NJ, Fuller TF, Klawitter J, Freise CE, Hirose R, Niemann CU: Metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplant model based on 1H-MRS metabonomics. American Transplant Congress, Boston, MA, May 15.-19., 2004.

  60. Serkova NJ, Snell L, Lapadat R, Tabakoff B: 1H-MRS based metabolomics on human plasma samples from alcoholic subjects. RSOA, Vancouver, BC July 9-11, 2004.

  61. Miljus J, Trump S, Brown J, Leibfritz D, Eckhardt SG, Serkova N: MRS assessment on metabolic response to a novel EGFR inhibitor ZD1839 in colon cancer cells. ISMRM Cancer Workshop, Manchester, U.K., October 3-5, 2004.

  62. Miljus J, Melo JV, Boros L, Anderson N, Talpaz M, Leibfritz D, Eckhardt SG, Serkova N: Metabolic profile of imatinib resistance in CML cells. 46th American Society of Hematology Annual Meeting, December 4-7, 2004, San Diego, CA.

  63. Wischmeyer PE, Singleton KD, Serkova N: Glutamine attenuates multiple pathways of sepsis-induced injury and improves survival following peritonitis: Role of heat stress protein pathway manipulation. Society for Critical Care Medicine, Orlando, FL, 2004.

  64. Serkova NJ, Melo JV, Eckhardt SG: Resistance to Imatinib and glucose metabolism. 96th Annual Meeting of American Association for Cancer Research (AACR), Anaheim, CA, April 15-20, 2005.

  65. Miljus J, Melo JV, Anderson N, Boros L, Eckhardt SG, Serkova NJ: MRS ability to predict resistance development to imatinib mesylate. 13th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Miami, FL, May 7-13, 2005.

  66. Gamito EJ, Serkova N, Jones RH, O’Donnel C, Hedlund T, Crawford ED: Nuclear magnetic resonance spectroscopy of expressed prostatic secretions: Metabolite citrate and derivatives are potential markers of prostate cancer. American Urological Association 2005 Annual Meeting, San Antonio, TX, May 21-26, 2005.

  67. Neville MC, Rudolph M, Serkova N, Anderson S: Molecular anatomy of a profound hormone regulated metabolic switch: Regulation of glucose and lipid metabolism during the initiation of lactation. 87th Annual Meeting of the Endocrine Society, San Diego, CA, June 4-7, 2005.

  68. Peng ZY, Serkova NJ, Kominsky DJ, Brown JL, Wischmeyer PE: Glutamine-mediated attenuation of cellular metabolic dysfunction and cell death following injury is dependent on heat shock factor-1 expression. Clinical Nutrition Week 2006, Dallas, TX, February 12-15, 2006.

  69. Serkova NJ, Gamito E, Brown JL, Crawford ED: Validation of citrate and derivatives in expressed prostatic secretions to predict prostate cancer: High-resolution 1H-NMR study. 97th Annual Meeting of American Association for Cancer Research (AACR), Washington DC, April 1-5, 2006.

  70. Serkova NJ, Gamito EJ, Jones RH, O’Donnell C, Crawford ED: Nuclear magnetic resonance spectroscopy of expressed prostatic secretions: Metabolite citrate and derivates are potential markers of prostatic cancer. 2006 American Society of Clinical Oncology (ASCO) Annual Meeting, Atlanta, GA, June 2-6, 2006.

  71. Serkova NJ, Bradshaw EL, Brown M, Gustafson DK, Henthorn TK: Assessment of tumor neovasculature by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) and compartmental modeling in nude mouse MCF-7 xenografts. 5th Annual Meeting of Molecular Imaging, Big Island, Hawaii, August 29 – September 2, 2006.

  72. Serkova NJ, Troiani T, Henthorn TK, Eckhardt SG: Novel dual VEGF-R and EGF-R inhibitor decreases tumor growth and angiogenesis in colon cancer mouse xenografts. 5th Annual Meeting of Molecular Imaging, Big Island, Hawaii, August 29 – September 2, 2006.

  73. Larsen BA, Barker AJ, Shandas R, Serkova NJ, Shroyer R, Stoldt CR: Molecular magnetic resonance imaging of human ovarian carcinoma cells using superparamagnetic immunomicells. 5th Annual Meeting of Molecular Imaging, Big Island, Hawaii, August 29 – September 2, 2006.

  74. Serkova NJ: Quantitative Metabolic Markers by High-Resolution Magnetic Resonance Spectroscopy. 232nd National Meeting of the American Chemical Society, San Francisco, CA, September 10-12, 2006.

  75. Serkova NJ, Troiani T, Bradshaw-Pierce EL, Henthorn TK, Gustafson DL, Eckhardt SG: Inhibition of tumor growth and angiogenesis by a novel dual EGF-R and VEGF-R inhibitor in mouse xenograft model: a DCE-MRI study. ISMRM Workshop on Cancer Metabolism and Physiology, Pocono Manor, PA, October 8-11, 2006.

  76. Serkova NJ, Gamito EJ, O’Donnell C, Brown JL, Hedlund T, Jones RH, Crawford ED: NMR spectroscopic validation of metabolic markers of prostatic cancer in human expressed prostatic secretions. ISMRM Workshop on Cancer Metabolism and Physiology, Pocono Manor, PA, October 8-11, 2006.

  77. Larsen BA, Haag MA, Serkova NJ, Stoldt CR: Molecular magnetic resonance imaging (MRI) in human carcinoma cells using superparamagnetic immunomicells. Signaling Transduction Modulators Symposium, Aurora, CO, December 7-8, 2006.

  78. Serkova NJ, Kominsky DJ, Brown JL, Miljus J, Boros LG, Eckhardt SG, Melo JV: Abnormalities in glucose uptake and metabolism in imatinib-resistant Bcr-Abl positive cells. 48th Annual Meeting of the American Society of Hematology (ASH), Orlando, FL, December 9-12, 2006.

  79. Tissot van Patot MC, Serkova NJ, Haschke M, Kominsky DJ, Roach R, Sheen P, Griffith V, Roosa J, Henthorn TK, Honigman B: Elevated circulating succinate and lactate, urinary 15-F21-isoprostanes as biological markers for hypoxic response in humans acutely exposed to 4,200 m. 15th International Hypoxia Symposium, Lake Louise, Alberta, Canada, February 27-March 4, 2007.

  80. Larsen BA, Haag MA, Serkova NJ, Stoldt CR: Effects of surface chemistry and magnetic anisotropy of superparamagnetic iron oxide nanoparticles for molecular magnetic resonance imaging. 2007 Material Research Society (MRS) Spring Meeting, San Francisco, CA, April 9-13, 2007.

  81. Serkova NJ, Takahashi H, Jiang T, Wang X, Brown JL, Kominsky DJ, Moshe L: Consequences of dietary modification on metabolic profile in SREBP-1c knockout mice. 2007 Experimental Biology Annual Meeting, Washington, DC, April 28-May 2, 2007.

  82. Larsen BA, Scaft KM, Haag MA, Serkova NJ, Shroyer KR, Stoldt CR: Molecular magnetic resonance imaging (MRI) of surface-epithelial-derived protein CA125 in human ovarian carcinoma cells using superparamagnetic immunomicelles. 15th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Berlin, Germany, May 19-25, 2007.

  83. Kraft S, Lana S, Tuttle H, Ireland L, Brown JL, Serkova NJ: Biopsy-based 1H- and 31P-NMR shows regional metabolic heterogeneity within canine spontaneous tumors. 15th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Berlin, Germany, May 19-25, 2007.

  84. Zhang L, Chan D, Weisman A, Balamurugan A, Serkova N, Chan L: Short report on NMR imaging of human islets labeled with nanoparticles. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

  85. Serkova NJ, Coatney JL, Fuller TF, Wachs ME, Freise C, Mandell MS, Niemann CU: Establishing metabolic profiling of delayed graft function in kidney recipients. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

  86. Serkova NJ, Neville M, Anderson S: Activated AKT1 accelerates mammary tumorigenesis in the MMTV-C-ERBB2 transgenic mouse model without activation of ERBB3 and stimulates glycolysis. The 89th Annual Meeting of the Endocrine Society, Toronto, ON, June 2-5, 2007.

  87. Tissot van Patot MC, Burton G, Jauniaux E, Serkova N: Oxidative stress and energy metabolism are similar between healthy and preeclampic placentas at altitude but not between preeclamptic placentas at low vs. high altitude. The 13th Annual Meeting of the International Federation of Placenta Association (IFPA), Kingston, ON, August 17-22, 2007.

  88. Larsen BA, Haag MA, Serkova NJ, Stoldt CR: Micellar multi-SPIO molecular gents: synthesis and characterization of a novel SPIO aggregate for in vivo ovarian cancer imaging. The Joint Molecular Imaging Conference, Providence, RI, September 8-11, 2007.

  89. Bradshaw-Pierce EL, Hasebroock KM, Brown JL, Henthorn TK, Levi M, Serkova NJ: Assessment of kidney function using DCE-MRI in a mouse nephrectomy model. The Joint Molecular Imaging Conference, Providence, RI, September 8-11, 2007.

  90. Kaufman SA, Pitts TM, Serkova NJ, Stephens A, Eckhardt SG, Leong S: In vitro assessment of the IGF-1R inhibitor, PQIP, alone and in combination with chemotherapy, against human colorectal cancer cell lines: antiproliferative, molecular, and metabolic effects. The 19th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Geneva, Switzerland, October 21-25, 2007.

  91. Glunde K, Bhujwalla ZM, Takagi T, Brown JL, Serkova N: Drug resistance in chronic myeloid leukemia increases cellular choline kinase and phosphocholine levels. 99th AACR Annual Meeting 2008, San Diego, CA, April 12-16, 2008.

  92. Kominsky DJ, Bradshaw-Pierce EL, Brown JL, Raben D, Gustafson DL, Serkova NJ: In vivo and in vitro metabolic effects of gefitinib and vandetanib in human head and neck cancer models. 99th AACR Annual Meeting 2008, San Diego, CA, April 12-16, 2008.

  93. Stringer KA, Pitzer MS, Wilkinson JE, Serkova NJ: Utility of magnetic resonance imaging and spectroscopy-based metabolomics for the quantification of inflammatory lung injury. The American Thoracic Society (ATS) 2008, Toronto, ON, May 16-21, 2008.

  94. Hasebroock KM, McClure WC, Tseng BS, Serkova NJ: Gadolinium-enhanced T1-MRI pinpoints skeletal muscle pathology in dystrophin deficient mice. The World Molecular Imaging Congress, Nice, France, September 10-13, 2008.

  95. Spratlin J, Eckhardt SG, Serkova NJ, Scurr M, Kaye SB, Collins D, George S, Demetri GD, Brock K, Stephens A, Camidge DR: Analyses of pharmacodynamic (PD) assessments collected during expanded cohorts (EC) of a phase I trial with OSI-930, a multi-targeted oral tyrosine kinase inhibitor (TKI). 20th EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”, Geneva, Switzerland, October 21-24, 2008.

  96. Serkova NJ, Spratlin J, Eckhardt SG, Milestone B, Youssoufian H, Fox F, Rowinsky E, Cohen RB: DCE-MRI endpoints reveal decreased tumor vascularity in patients with liver metastases: a Phase I dose escalating study with IMC-1121B. 20th EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”, Geneva, Switzerland, October 21-24, 2008.

  97. Tentler JJ, Pierce ELB, Serkova NJ, Pitts TM, Bray MR, Fletcher GC, Eckhardt SG: ENMD-2076 exerts antiangiogenic and antiproliferative activity against human colorectal cancer (CRC) xenograft models. 20th EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”, Geneva, Switzerland, October 21-24, 2008.

  98. DeRyckere D, Serkova N, Macy M, Gardner L, Jedlicka P, Hasebroock K, Gore L: In vivo imaging of leukemia in MLL-AF9 transgenic mice using magnetic resonance imaging and spectroscopy. 50th American Society of Hematology (ASH) Annual Meeting, San Francisco, CA, December 6-9, 2008.

  99. Ziran NM, Roper E, King KB, Serkova NJ, Hak DJ: The effect of stem cell donor age on in vivo bone formation. Orthopaedic Research Society (ORS) 55th Annual Meeting, Las Vegas, NV, February 22-25, 2009.

  100. Bradshaw-Pierce EL, Hasebroock KM, Merz AL, Tentler JJ, Eckhardt SG, Serkova NJ: Quantitative assessment of treatment response to molecularly targeted agents by DCE-MRI and 18FDG-PET in Colorectal Cancer Mouse Models. 4th Imaging in Pre-Clinical and Clinical Drug Development Conference, San Francisco, CA, March 16-18, 2009.

  101. Serkova NJ, Raina K, Merz AL, Agarwal R: Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: a 1H-NMR study. 17th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, HI, April 18-24, 2009.

  102. Serkova NJ, Larsen BA, Renner B, Hasebroock KM, Bradshaw-Pierce EL, Holers M, Stoldt C, Thurman JM: Molecular imaging using targeted nanoparticles for non-invasive detection of renal inflammation. 17th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, HI, April 18-24, 2009.

  103. DeRyckere D, Macy ME, Hasebroock KM, Gardner LA, Jedlicka P, Bradshaw-Pierce EL, Merz AL, Gore L, Serkova NJ: MRI/ MRS on leukemia development in MLL-AF9 transgenic mice. 17th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, HI, April 18-24, 2009.

  104. Bradshaw-Pierce EL, Hasebroock KM, Merz AL, Tentler JJ, Eckhardt SG, Serkova NJ: Quantitative DCE-MRI and positron emission tomography (PET) for assessment of treatment response in a mouse xenograft model of colorectal cancer. 17th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, HI, April 18-24, 2009.

  105. Raina K, Serkova NJ, Agarwal R: Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study. 100th AACR Annual Meeting 2009, Denver, CO, April 12-16, 2009.

  106. Dang K, Melcher ML, Park Y, Hirose R, Serkova NJ, Niemann CU: Targeted quantitative metabolomics in rats during the early reperfusion period. ILTS 15th Annual International Congress, New York, NY, July 8-11, 2009.

  107. Cohen MJ, Serkova NJ, Wiener-Kronish J, Pittet JF, Niemann CU: 1H-NMR based metabolic signatures in trauma patients: Metabolic profiling beyond lactate and basis deficit. 68th Annual Meeting of the American Association for the Surgery and Trauma, Pittsburgh, PA, October 1-3, 2009.

  108. DeRyckere D, Gore L, Gardner LA, Merz AL, Serkova N: Identification of altered metabolic pathways in a mouse model of acute myeloid leukemia. 21st EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”, Boston, MA, October 21-24, 2009.

  109. Serkova NJ, Hasebroock KM, Bradshaw-Pierce EL, Stoldt C, Thurman JM: Molecular imaging for non-invasive detection of renal inflammation by MRI. 57th Annual Meeting of the Association of University Anesthesiologists (AUA), Denver, CO, April 8-10, 2010.

  110. Ramasamy K, Nield LD, Serkova NJ, Hasebroock KM, Tyagi A, Raina K, Malkinson AM, Agarwal R: Silibinin selectively inhibits growth and progression of urethane-induced lung tumors in wild-type but not inducible nitric oxide synthase (-/-) mice: potential usefulness of micro-CT in lung cancer chemoprevention studies. AACR 101st Annual Meeting, Washington, DC, April 17-21, 2010.

  111. Raina K, Ravichandran K, Rajamanickam S, Hasebroock KM, Serkova NJ, Agarwal R: Energy deprivation by inositol hexaphospatase inhibits prostate tumor growth and progression in TRAMP mice. AACR 101st Annual Meeting, Washington, DC, April 17-21, 2010.

  112. Raina K, Agarwal C, Serkova NJ, Agarwal R: Molecular mechanism of cell death by silibinin in colorectal cancer: apoptosis versus autophagy. AACR 101st Annual Meeting, Washington, DC, April 17-21, 2010.

  113. Wu PH, Fay T, Serkova NJ, Beresford TP: Cyclosporine reduces alcohol consumption independent of sucrose consumption in C57BL mice. 33rd Annual Research Society of Alcoholism (RSA) Scientific Meeting, San Antonio, TX, June 26-30, 2010.

  114. Kraft S, Lana S, Ehrhart EJ, Carlsten K, Merz AL, Bucy D, Serkova NJ: Metabolic response to chemotherapy in multicentric canine lymphoma by biopsy-based nuclear magnetic resonance (NMR) spectroscopy. World Molecular Imaging Conference, Kyoto, Japan, September 8-11, 2010.

  115. Serkova NJ and Eckhardt SG: Differential responses to cytotoxic and cytostatic agents by metabolic and functional imaging end-points. ISMRM Scientific Workshop on Advanced Cancer MRI, Santa Cruz, CA, September 19-22, 2010.

  116. Serkova NJ, Bradshaw-Pierce EL, Hasebroock KM, Merz AL, Pitts TM, Eckhardt SG: Imaging end-points to predict response to IGF1R/IR inhibition in CRC models. AACR Molecular Diagnostics in Cancer Therapeutic Development: Challenges and New Horizons Conference, Denver, CO, September 27-30, 2010.

  117. Strand K, Loram LC, Taylor FR, Sloane EM, Rieger J, Maier SF, Serkova NJ, Watkins LR: Adenosine 2A receptor (A2aR) agonists in multiple sclerosis in rats: multi-week resolution of pain or paralysis with single intrathecal (IT) dosing. Society for Neuroscience Annual Meeting, San Diego, CA, November 13-17, 2010.

  118. Frey L, Lepkin A, Schickedanz A, Hasebroock KM, Serkova NJ: Blood-brain barrier disruption (BBBD) by T1-weighted MRA as a biomarker for seizure susceptibility after experimental brain injury. 64th Annual Meeting of the American Epilepsy Society, San Antonio, TX, December 3-7, 2010.

  119. Sargsyan SA, Serkova NJ, Renner B, Hasebroock KM, Larsen B, Stoldt C, McFann K, Thurman JM: MRI-based detection of tissue fixed complement C3 fragments to monitor disease activity in lupus nephritis. 19th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Montreal, QE, Canada, May 3-8, 2011.

  120. Fredrickson J, Serkova N, Carano R, Wyatt S, Pirzkall A, Weekes C, Silverman J, Rosen L, de Crespigny A: Clinical translation of VSI using Ferumozytol: Feasibility in a phase I oncology clinical trial population. 20th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Melbourne, Australia, May 5-11, 2012.

  121. Bluth JS, Loram LC, Brown MS, Hasebroock KM, Miller DE, Watkins LR, Serkova NJ: MRI detection of spinal lesions in a rat MS model. 20th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Melbourne, Australia, May 5-11, 2012.

  122. Serkova NJ, Bradshaw-Pierce EL, Rowe MD, Hasebroock KM, Merz AL, Boyes SG: Targeted gadolinium MOF nanoparticles as a positive contrast for MR imaging on EGFR expression. 20th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Melbourne, Australia, May 5-11, 2012.

  123. Yang T, Serkova NJ, Lim L, Maze M, Niemann CU: Xenon and isoflurane preconditioning elevate the mitochondrial function related gene expression in the liver in rat. American Society of Anesthesiology (ASA) Annual Meeting, Washington, D.C., October 13-17, 2012.

  124. Serkova NJ, Huber KM, Renner B, Pickering MC, Thurman JM: Non-invasive detection of glomerulonephritis by MRI-based molecular imaging. The American Nephrology Society (ASN) Kidney Week 2012 Annual Meeting, San Diego, CA, November 1-4, 2012.

  125. Stukova M, Golovko D, Huber K, Frederick B, Thurman J, Serkova NJ: Time-course for macrophage detection in vivo by ferumoxytol-enhanced T2-MRI. The 2013 World Molecular Imaging Conference (WMIC), Savannah, GA, September 18-21, 2013.

  126. Schlaepfer I, Eckel R, Serkova NJ, Glode M, Cramer S: Enhancement of 18-FDG-PET in prostate cancer xenografts using lipid metabolic inhibitors. The 2013 World Molecular Imaging Conference (WMIC), Savannah, GA, September 18-21, 2013.

  127. Serkova NJ, Huber KM, Hicks D, Smith-Jones P, Spillman MA: 18F-Estrogen PET in orthotopic mouse xenograft models for ovarian cancer. American Association for Cancer Research (AACR) Ovarian Cancer Workshop, Miami, FL, September 18-20, 2013.

  128. Serkova NJ, Hammond BG, Poth J, Huber KM, Stukova M, Golovko D: Magnetic resonance imaging (MRI) on macrophage-based inflammation in a mouse renal ischemia-reperfusion model using super-paramagnetic iron oxide (SPIO) nanoparticles. American Society of Anesthesiology (ASA) Annual Meeting, San Francisco, CA, October 12-16, 2013.

  129. Henry CJ, Marusyk A, Zaberezhnyy V, Casas-Selves M, Serkova NJ, DeGregori J: Inflamm-aging reduces B-progenitor function leading to increased selection for oncogenically-initiated B-cells. Inflammation, Infection and Cancer (X1) Keystone Meeting, Whistler, British Columbia, Canada, March 9-14, 2014.

  130. Deep G, Ramteke AM, Nambiar DK, Jain AK, Serkova NJ, Agarwal C, Agarwal R: Silibinin inhibits hypoxia-induced proliferation, angiogenesis and lipogenesis in prostate cancer cells both in vitro and in vivo. American Association for Cancer Research (AACR) Annual Meeting, San Diego, CA, April 5-9, 2014.

  131. Schlaepfer IR, Pac CT, Serkova NJ, Deep G, Agarwal R, Cramer SD, Eckel RH, Glode LM: Lipid metabolism inhibitors enhance glycolysis and FDG uptake by PET in prostate cancer tumors. American Association for Cancer Research (AACR) Annual Meeting, San Diego, CA, April 5-9, 2014.

  132. Lee JY, Wilson LA, Choi JM, Huber KM, Merz AL, Weekes CD, Serkova NJ: A multimodality imaging end-point study of everolimus and ganetespib in treatment of pancreatic cancer: a pre-clinical PET/MRI/MRS study. American Association for Cancer Research (AACR) Annual Meeting, San Diego, CA, April 5-9, 2014.

  133. Borgen LK, Murphy CM, Johnson EL, Sinha N, Serkova NJ, Drew KL: 1H-NMR metabolomics biomarkers of poor outcome after hemorrhagic shock are absent in hibernators. Experimental Biology Conference, San Diego, CA, April 26-30, 2014.

  134. Lee JY, Wilson LA, Choi JM, Huber KM, Merz AL, Kechris KJ, Weekes CD, Serkova NJ: Multimodality imaging end-points on mTOR and HSP inhibition in pancreatic cancer: A pre-clinical PET/MRI/MRS study. 22nd Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Milan, Italy, May 9-16, 2014.

  135. Stringer KA, Jones AE, Puskarich MA, Karnovsky A, Serkova NJ: Increased lipid levels by 1H-NMR associated with apoptosis differentiate acute respiratory distress syndrome (ASRD) from sepsis. American Thoracic Society (ATS) Conference, San Diego, CA, May 16-21, 2014.

  136. Little T, Ryan AJ, Steffens FE, Serkova NJ, Meyer D: Associative metabolic changes in HIV-1 infected patients, influence of ART and quantitative lipid analyses using 1H-NMR. Kern Lipid Conference 2014, Vail, CO, August 4-7, 2014.





Download 376.88 Kb.

Share with your friends:
1   2   3   4




The database is protected by copyright ©ininet.org 2022
send message

    Main page